Kuang-Tien General Hospital

Taichung 43303

1 studies enrolling now · 8 studies all time

What they study most

Brain Infarction, Cerebral Ischemia, Diabetes Mellitus, Type 2, Endometrial Cancer, HER2+ Metastatic Breast Cancer (MBC), Heart Failure, Obesity, Overweight, Peripheral Arterial Disease, Stroke, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer — Recruiting now
• A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight — Withdrawn before enrolling
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes — Completed
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed
• Study of AC-201 in Patients With Type 2 Diabetes Mellitus — Completed
• Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early